Dietary Supplement Listing Act of 2026

Key Points

• This bill would require every company that makes, packs, or distributes dietary supplements sold in the U.S. to register each product with the FDA. This is a new requirement that does not currently exist in federal law.
• Companies must submit detailed product information including the product name, a copy of the label, a full ingredient list with amounts per serving, health claims, allergen warnings, and directions for use.
• The FDA would build a free, public online database where consumers can search for any supplement by name, listing number, or ingredient to see what is actually in it and what health claims the company makes.
• Supplements already on the market would need to be registered within 18 months of the law passing. New products would need to register before going on sale. Products that fail to register would be considered misbranded and illegal to sell.
• Proprietary blend ingredient amounts and business contact details would stay confidential and be shielded from public disclosure, protecting trade secrets while still giving the FDA oversight.
• The bill authorizes about $7.9 million for the first year and $6.6 million per year after that through 2030 to fund the FDA's work building and running the new registration system.

Votes

No votes have been recorded for this legislation yet.